Chong Kun Dang Pharmaceutical Corp (185750):企業の財務・戦略的SWOT分析

◆英語タイトル:Chong Kun Dang Pharmaceutical Corp (185750) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0975
◆発行会社(調査会社):GlobalData
◆発行日:2020年1月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Chong Kun Dang Pharmaceutical Corp (185750) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Chong Kun Dang Pharmaceutical Corp (CKD Pharma) manufactures, distributes, imports and exports prescription drugs, active pharmaceutical ingredients (APIs), over-the-counter (OTC) drugs, health supplements and consumer health products. Its product portfolio includes prescription products for the entire segment and therapeutic classes; vitamins; shampoos; hair colors; aerosols; mat vaporizers and mosquito coils; and others. The company’s Chong Kun Dang Research Institute is characterized by three independent laboratories, namely, The New Drug Discovery Labs; The Technology Development Labs; and the Bio Research Labs. The company has presence in Japan, Korea, Vietnam and China. CKD Pharma is headquartered in Seoul, South Korea..

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Chong Kun Dang Pharmaceutical Corp – Key Facts
Chong Kun Dang Pharmaceutical Corp – Key Employees
Chong Kun Dang Pharmaceutical Corp – Major Products and Services
Chong Kun Dang Pharmaceutical Corp – History
Chong Kun Dang Pharmaceutical Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Chong Kun Dang Pharmaceutical Corp – Business Description
Chong Kun Dang Pharmaceutical Corp – SWOT Analysis
SWOT Analysis – Overview
Chong Kun Dang Pharmaceutical Corp – Strengths
Chong Kun Dang Pharmaceutical Corp – Weaknesses
Chong Kun Dang Pharmaceutical Corp – Opportunities
Chong Kun Dang Pharmaceutical Corp – Threats
Chong Kun Dang Pharmaceutical Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Chong Kun Dang Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Chong Kun Dang Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Chong Kun Dang Pharmaceutical Corp, Recent Deals Summary
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Chong Kun Dang Pharmaceutical Corp, Key Facts
Chong Kun Dang Pharmaceutical Corp, Key Employees
Chong Kun Dang Pharmaceutical Corp, Major Products and Services
Chong Kun Dang Pharmaceutical Corp, History
Chong Kun Dang Pharmaceutical Corp, Other Locations
Chong Kun Dang Pharmaceutical Corp, Key Competitors
Chong Kun Dang Pharmaceutical Corp, Ratios based on current share price
Chong Kun Dang Pharmaceutical Corp, Annual Ratios
Chong Kun Dang Pharmaceutical Corp, Annual Ratios (Cont...1)
Chong Kun Dang Pharmaceutical Corp, Annual Ratios (Cont...2)
Chong Kun Dang Pharmaceutical Corp, Interim Ratios
Chong Kun Dang Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Chong Kun Dang Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Chong Kun Dang Pharmaceutical Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Chong Kun Dang Pharmaceutical Corp, Performance Chart (2014 - 2018)
Chong Kun Dang Pharmaceutical Corp, Ratio Charts
Chong Kun Dang Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Chong Kun Dang Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Chong Kun Dang Pharmaceutical Corp (185750):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ferrovial SA (FER):企業の財務・戦略的SWOT分析
    Ferrovial SA (FER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Paragon Offshore Plc:石油・ガス:M&Aディール及び事業提携情報
    Summary Paragon Offshore Plc (Paragon Offshore) is an oil and gas company that offers offshore drilling rigs. The company provides contract drilling, maintenance and fleet management services. It operates through a fleet of rigs including Jackup rigs, Drillships and semi submersible rigs. Paragon Of …
  • Flex Foods Ltd:企業の戦略・SWOT・財務分析
    Flex Foods Ltd - Strategy, SWOT and Corporate Finance Report Summary Flex Foods Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Tata Steel Group:企業のM&A・事業提携・投資動向
    Tata Steel Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Tata Steel Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Mirage Retail Group BV:企業の戦略的SWOT分析
    Mirage Retail Group BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Targovax ASA (TRVX):企業の財務・戦略的SWOT分析
    Summary Targovax ASA (Targovax) is a developer and commercializer of immunotherapies for the treatment of cancer patients. The company’s lead candidates include TG01, a peptide-based therapeutic anti-cancer vaccine under development for pancreatic cancer; and ONCOS-102 is an adenovirus-based pipelin …
  • Organo Corporation:企業の戦略・SWOT・財務情報
    Organo Corporation - Strategy, SWOT and Corporate Finance Report Summary Organo Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Re-Vana Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Re-Vana Therapeutics Ltd (Re-Vana) is an ocular pharmaceutical and drug delivery company that develops and commercialization of biodegradable long- acting drug delivery platforms to treat ophthalmic conditions. The company provides drug delivery products such as OcuLief, an injectable platfo …
  • Long Run Exploration Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Long Run Exploration Ltd (Long Run), formerly WestFire Energy Ltd, a subsidiary of Calgary Sinoenergy Investment Corp, is an oil and gas company that offers development and exploration of light oil. The company grows crude oil volumes within its diversified portfolio properties. Its oil expl …
  • Fuji Chemical Industry Co Ltd:企業の戦略・SWOT・財務情報
    Fuji Chemical Industry Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Fuji Chemical Industry Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Aarti Drugs Ltd (AARTIDRUGS):企業の財務・戦略的SWOT分析
    Summary Aarti Drugs Ltd (ADL), is a contract manufacturer of pharmaceutical products that offers therapeutic products, ingredients, bulk drugs, and chemicals. The company's products include active pharmaceutical ingredients, pharma intermediates, and specialty chemicals. Its active pharmaceutical in …
  • CVRx Inc-医療機器分野:企業M&A・提携分析
    Summary CVRx Inc (CVRx) is a medical device company that develops and designs implantable device. The company offers barostim neo system, which is designed to trigger the body’s natural blood flow regulation system to treat high blood pressure and heart failure. Its products are used in the treatmen …
  • Playtech PLC:企業のM&A・事業提携・投資動向
    Playtech PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Playtech PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Ctrip.com International, Ltd.:企業の戦略・SWOT・財務情報
    Ctrip.com International, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ctrip.com International, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • EWE AG:企業の戦略的SWOT分析
    EWE AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Payton Planar Magnetics Ltd (PAY):企業の財務・戦略的SWOT分析
    Payton Planar Magnetics Ltd (PAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • First Bancorp. (FBP):企業の財務・戦略的SWOT分析
    First Bancorp. (FBP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • MallInckrodt Plc (MNK)-製薬・医療分野:企業M&A・提携分析
    Summary Mallinckrodt Plc (Mallinckrodt) is a healthcare products provider that offers generics and active pharmaceutical ingredients. The company offers generic products which include addiction treatment products, compounding powders, unit dose products and resource tool kits. Its active pharmaceuti …
  • Precision Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Precision Biologics Inc (PBI), a subsidiary of NantWorks LLC, is a clinical stage biotechnology company. The company offers cancer vaccines, antigens and antibodies, pipelines, diagnostics, therapeutics, clinical trials, tumor specific antigens, companion diagnostic programs, and diagnostic …
  • Xylem Inc (XYL):電力:M&Aディール及び事業提携情報
    Summary Xylem Inc (Xylem) is a water technology company. It designs, manufactures, and services engineered solutions ranging across a wide variety of applications. The company’s offerings address customer needs across the water cycle, from the delivery, measurement and use of drinking water to the c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆